Table 2.
Measurement 1 (n=24) | Measurement 2 (n=24) | Measurement 3 (n=8) | Control Subjects (n=29) | |||
---|---|---|---|---|---|---|
|
|
|||||
MAP (mmHg) | 107.2 +/− 19 | 105 +/− 17.1 | 104 +/− 20.5 | 87 +/− 16.3 | ||
|
|
|||||
CBFV (cm/sec) | Affected | 58.5 +/− 24.1 | 51.9 +/− 18.1 | 53.8 +/− 19.5 | Left | 52.8 +/− 13.6 |
Unaffected | 56.5 +/− 22.3 | 54.1 +/− 14.5 | 55.7 +/− 14.8 | Right | 52.6 +/− 13.7 | |
|
|
|||||
Pulsatility Index | Affected | 0.97 +/− 0.25 | 0.97 +/− 0.25 | 0.91 +/− 0.17 | Left | 0.75 +/− 0.13 |
Unaffected | 0.99 +/− 0.22 | 1.02 +/− 0.24 | 0.93 +/− 0.16 | Right | 0.77 +/− 0.14 | |
|
|
|||||
Phase Shift (degrees) | Affected | 29.6 +/− 10.5 | 23.2 +/− 19.1 | 53.2 +/− 28.2 | Left | 47 +/− 17.5 |
Unaffected | 42.5 +/−13 | 41.7 +/−18.5 | 50.7 +/− 29.2 | Right | 48.7 +/− 16.3 |